Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Mancino

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Microbiome Research Reports|April 10, 2025
Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulinNancy My Teng, Andrea Malfettone, Matthew J Dalby, et al.
International Journal of Cancer|January 17, 2020
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancerAnna López-Plana, Patricia Fernández-Nogueira, Pau Muñoz-Guardiola, et al.
The Lancet. Oncology|July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysisGuillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
EMBO Molecular Medicine|August 11, 2021
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Francesca Mateo, Alexandra Baiges, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Microbiome Research Reports|April 10, 2025
Profiling the gut and oral microbiota of hormone receptor-positive, HER2-negative metastatic breast cancer patients receiving pembrolizumab and eribulinNancy My Teng, Andrea Malfettone, Matthew J Dalby, et al.
International Journal of Cancer|January 17, 2020
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancerAnna López-Plana, Patricia Fernández-Nogueira, Pau Muñoz-Guardiola, et al.
The Lancet. Oncology|July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysisGuillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
EMBO Molecular Medicine|August 11, 2021
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Francesca Mateo, Alexandra Baiges, et al.
Pageof 4